Skip to Main Content
Home
Search
Study Topics
Glossary
Full Text View
Tabular View
No Study Results Posted
Related Studies
Angiotensin Converting Enzyme Inhibitors in Marfan Syndrome
This study has been completed.
Study NCT00485368 Information provided by Bayside Health
First Received: June 11, 2007 Last Updated: June 12, 2007
History of Changes
Related Studies can be found by searching for the Conditions, Interventions, and Sponsors found in this study:
Conditions listed in this trial
Marfan Syndrome
Additional conditions recognized in this trial
Arachnodactyly
Syndrome
More general conditions related to this trial
Abnormalities, Multiple
Bone Diseases
Bone Diseases, Developmental
Cardiovascular Abnormalities
Cardiovascular Diseases
Congenital Abnormalities
Connective Tissue Diseases
Disease
Genetic Diseases, Inborn
Heart Defects, Congenital
Heart Diseases
Limb Deformities, Congenital
Musculoskeletal Abnormalities
Musculoskeletal Diseases
Pathologic Processes
Interventions listed in this trial
Coversyl (perindopril)
Additional drug interventions recognized in this trial
Angiotensin-Converting Enzyme Inhibitors
Enzyme Inhibitors
Perindopril
More general drug interventions related to this trial
Antihypertensive Agents
Cardiovascular Agents
Molecular Mechanisms of Pharmacological Action
Pharmacologic Actions
Protease Inhibitors
Therapeutic Uses
Sponsors listed in this trial
Bayside Health
Baker Heart Research Institute
The Alfred
Back to top of Main Content
